Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

KRO vs HDSN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KRO Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

KRO Overall Winner 6-Pillar Tally: KRO 3 – 3 HDSN Matrix Metrics: KRO 7 – 3 HDSN

As of Nov 16, 2026, Kronos Worldwide, Inc. (KRO) is the stronger overall head-to-head candidate over Hudson Technologies Inc (HDSN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). KRO carries a Unified Composite Score of 42.2/100 (HOLD) at $7.82 (13.5x Forward P/E, 2.4% operating margin), whereas HDSN carries 53.2/100 (HOLD) at $4.25 (25.9x Forward P/E, 2.0% operating margin).

  • Composite vs. Pillar Nuance: While HDSN currently prints a higher short-term Unified Composite Score (53.2/100 HOLD vs. KRO 42.2/100 HOLD), KRO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (2.4% vs. 2.0% operating margin) and revenue trajectory (+18.4% vs. -19.7% YoY).
  • Technical & Structure Timing Caution: KRO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.4); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KRO vs HDSN
KRO NYSE Head-to-Head Winner
Kronos Worldwide, Inc.
Industrial Inorganic Chemicals
$7.82
-5.67% 1D
Market Cap $968.0M
TTM Revenue $2.03B
Forward P/E 13.5x
Beta / 30D Vol 1.19β · 57% Vol
Unified Composite Score
42.2 / 100 HOLD
Tech 36.0 Fund 36.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.4 · SMA20: $7.77 · SMA50: $7.86
HDSN NASDAQ
Hudson Technologies Inc
Wholesale-Machinery, Equipment & Supplies
$4.25
-3.52% 1D
Market Cap $186.5M
TTM Revenue $242M
Forward P/E 25.9x
Beta / 30D Vol 1.32β · 68% Vol
Unified Composite Score
53.2 / 100 HOLD
Tech 67.0 Fund 65.0 Flow 55.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $4.68 · SMA50: $4.99

6-Pillar Scorecard Institutional Category Breakdown (KRO 3 – 3 HDSN)

Columns: Metric · KRO · HDSN
1. Valuation Multiples KRO
Forward P/E 13.5x 25.9x
Trailing P/E 4.9x 16.5x
PEG Ratio 1.36x 0.29x
EV / Revenue 0.5x 0.6x
2. Growth & Scale KRO
Revenue Growth (YoY) +18.4% -19.7%
Earnings Growth (YoY) +124.8% -82.0%
TTM Revenue (USD) $2.03B $242M
Market Cap $968.0M $186.5M
3. Profitability & Quality HDSN
Gross Margin 15.5% 21.0%
Operating Margin 2.4% 2.0%
Net Profit Margin -1.9% -0.5%
Return on Equity (ROE) -4.7% -0.5%
4. Balance Sheet & Cash Flow KRO
Cash Generation (TTM) $111M EBITDA -$32M
Cash Flow Margin 5.5% EBITDA Mgn -13.0%
Net Cash / Leverage $6.81 Book/Sh · -4.7% ROE $31M Net Cash
Dividend Yield 2.35% None (0.00%)
5. Options & Positioning HDSN
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 43.1% (25th %ile) 79.1% (15th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat HDSN
OpEx & R&D Intensity 13.1% of Rev ($266M) 19.0% of Rev ($46M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KRO (7) vs HDSN (3)
Institutional Metric KRO HDSN Criterion Row Edge
Market Capitalization
Scale
$968.0M $186.5M Larger Scale KRO
Trailing P/E Ratio
Valuation
4.9x 16.5x Lower Multiple KRO
Forward P/E Ratio
Valuation
13.5x 25.9x Lower Multiple KRO
Revenue Growth (YoY)
Growth
+18.4% -19.7% Higher Growth KRO
Operating Margin (TTM)
Profitability
2.4% 2.0% Higher Margin KRO
Net Profit Margin
Profitability
-1.9% -0.5% Higher Margin HDSN
Return on Equity (ROE)
Capital Efficiency
-4.7% -0.5% Higher ROE HDSN
52-Week Range Position
Momentum
72% ($4–$9) 6% ($4–$8) Stronger Trend KRO
Beta / 30D Volatility
Risk Regime
1.19β · 57% Vol 1.32β · 68% Vol Lower Realized Risk KRO
Unified Institutional Score
Composite Signal
42.2 / 100 (HOLD) 53.2 / 100 (HOLD) Higher Composite HDSN
Trailing 12M Revenue (USD)
Operating Scale
$2.03B $242M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
15.5% 21.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.36x PEG · 0.5x EV/Rev 0.29x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$111M EBITDA ($6.81 Book/Sh · -4.7% ROE) -$32M ($31M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KRO +20.52 pp
KRO: +5.25% · HDSN: -15.27%
3M Horizon KRO +23.28 pp
KRO: -1.39% · HDSN: -24.67%
6M Horizon KRO +27.9 pp
KRO: +13.66% · HDSN: -14.24%
1Y Horizon KRO +100.36 pp
KRO: +62.24% · HDSN: -38.12%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KRO vs HDSN. Trailing 12-month operating profitability (KRO 2.4% vs HDSN 2.0%) and valuation multiples (KRO 13.5x vs HDSN 25.9x Forward P/E) are benchmarked directly in Pillar 4 below.

KRO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.03B
Gross Margin15.5%
Op. Margin2.4%
ROE / Fwd P/E-4.7% · 13.5x
HDSN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$242M
Gross Margin21.0%
Op. Margin2.0%
ROE / Fwd P/E-0.5% · 25.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KRO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 43.1%
IV Percentile 25th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KRO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HDSN BREAKDOWN
90d in phase · OBV ACCUMULATION
Current IV 79.1%
IV Percentile 15th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KRO Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $968.0M market capitalization and 2.4% operating margin.
OpEx & R&D Reinvestment 13.1% of Rev ($266M)
90D Engineering Disclosures 0 Published
HDSN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $186.5M market capitalization and 2.0% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($46M)
90D Engineering Disclosures 0 Published

Investor FAQ KRO vs HDSN Key Questions & Quantitative Answers

As of Nov 16, 2026, Kronos Worldwide, Inc. (KRO) is the stronger overall head-to-head candidate over Hudson Technologies Inc (HDSN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). KRO carries a Unified Composite Score of 42.2/100 (HOLD) at $7.82 (13.5x Forward P/E, 2.4% operating margin), whereas HDSN carries 53.2/100 (HOLD) at $4.25 (25.9x Forward P/E, 2.0% operating margin). Composite vs. Pillar Nuance: While HDSN currently prints a higher short-term Unified Composite Score (53.2/100 HOLD vs. KRO 42.2/100 HOLD), KRO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (2.4% vs. 2.0% operating margin) and revenue trajectory (+18.4% vs. -19.7% YoY). Technical & Structure Timing Caution: KRO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.4); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KRO leads the Growth & Scale pillar: KRO posts +18.4% YoY revenue growth and +124.8% YoY earnings growth on $2.03B TTM revenue (15.5% gross margin, 2.4% operating margin), compared with HDSN at -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin). On trailing 12-month operating scale, KRO generates $2.03B in USD-normalized revenue versus $242M for HDSN. In operating R&D and SG&A reinvestment, KRO deploys 13.1% of Rev ($266M) (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($46M) (0 disclosures) for HDSN.

KRO screens cheaper on headline valuation multiples. KRO trades at 13.5x Forward P/E, 4.9x Trailing P/E, 1.36x PEG, and 0.5x EV/Revenue (5.5% EBITDA margin), whereas HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KRO (-4.7% ROE) versus HDSN (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, KRO carries 43.1% implied volatility (25th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 57% Vol realized risk). By comparison, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.